Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group (Q22253231)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group	scientific article

Statements

scholarly article

0 references

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group (English)

0 references

Gonadotropin releasing hormone receptor

1 reference

GOA release 2020-03-11

multicellular organism development

1 reference

GOA release 2020-03-11

7

object named as

P Devroey

author given names

P

author last names

Devroey

1 reference

PubMed publication ID

7 February 2023

author name string

C Albano

1

author given names

C

author last names

Albano

1 reference

PubMed publication ID

7 February 2023

R E Felberbaum

2

author given names

R E

author last names

Felberbaum

1 reference

PubMed publication ID

7 February 2023

J Smitz

3

author given names

J

author last names

Smitz

1 reference

PubMed publication ID

7 February 2023

H Riethmüller-Winzen

4

author given names

H

author last names

Riethmüller-Winzen

1 reference

PubMed publication ID

7 February 2023

J Engel

5

author given names

J

author last names

Engel

1 reference

PubMed publication ID

7 February 2023

K Diedrich

6

author given names

K

author last names

Diedrich

1 reference

PubMed publication ID

7 February 2023

language of work or name

0 references

publication date

March 2000

0 references

Human Reproduction

0 references

15

0 references

3

0 references

526-31

0 references

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Twin pregnancy after pituitary desensitisation with LHRH agonist and pure FSH.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotropin-releasing hormone antagonists: effects on the ovarian follicle and corpus luteum.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F15.3.526

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22253231&oldid=1975841098"